Laura Smy, PhD

Assistant Professor

view physician profile

Locations

Pathology - Froedtert Hospital

Specialties

Pathology

Languages

English

Education

                
                    Clinical Expertise
                
                    Clinical Chemistry Tests
Clinical Laboratory Services
Clinical Laboratory Techniques
Hair
Laboratory Critical Values
Laboratory Proficiency Testing
Medical Laboratory Science
Pharmacokinetics
Pharmacology, Clinical
Point-of-Care Testing
Pre-Analytical Phase
Pregnancy

                    Methodologies and Techniques
                
                    Chemistry Techniques, Analytical
Enzyme-Linked Immunosorbent Assay
Immunologic Techniques
Mass Spectrometry

                    Leadership Positions
                
                    Associate Laboratory Director - Pewaukee and New Berlin Community Hospitals
Co-Director of Chemistry/Toxicology - Wisconsin Diagnostic Laboratories
Section Director for Point-of-Care - Froedtert Hospital

A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine.

(Smy L, Kushnir MM, Frank EL.) J Mass Spectrom Adv Clin Lab. 2021 Aug;21:19-26 PMID: 34820673 PMCID: PMC8601001 11/26/2021
The nuclear magnetic resonance metabolic profile: Impact of fasting status.

(Smy L, De Biase I, Genzen JR, Yuzyuk T.) Clin Biochem. 2021 Jan;87:85-92 PMID: 33159964 11/08/2020
Evaluation of Imatinib Concentrations in Samples Submitted for BCR-ABL1 or Imatinib Testing-Evidence to Support Therapeutic Drug Monitoring for Dose Optimization?

(Smy L, Sadler AJ, McMillin GA.) Ther Drug Monit. 2020 Aug;42(4):559-564 PMID: 32697563 07/23/2020
Evaluation of imatinib concentrations in samples submitted for BCR-ABL1 or imatinib testing - evidence to support therapeutic drug monitoring for dose optimization?

(Smy L, Sadler AJ, McMillin GA.) Ther Drug Monit. 2020 May 06 PMID: 32384535 05/10/2020
Phlebotomy tube interference with nuclear magnetic resonance (NMR) lipoprotein subclass analysis.

(Needham LL, Smy L, Lee MA, Kunzler TM, Genzen JR.) Clin Chim Acta. 2019 Jan;488:235-241 PMID: 30414827 11/12/2018
Measuring estrogens in women, men, and children: Recent advances 2012-2017.

(Smy L, Straseski JA.) Clin Biochem. 2018 Dec;62:11-23 PMID: 29800559 05/26/2018
Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study.

(Smy L, Shaw K, Amstutz U, Staub M, Chaudhry S, Smith A, Carleton B, Koren G.) Clin Biochem. 2018 Jun;56:26-32 PMID: 29673814 04/21/2018
Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study.

(Smy L, Shaw K, Amstutz U, Smith A, Berger H, Carleton B, Koren G.) BMC Pregnancy Childbirth. 2016 Jul 20;16(1):176 PMID: 27440139 PMCID: PMC4955128 07/22/2016
Hair cortisol as a novel biomarker of HPA suppression by inhaled corticosteroids in children.

(Smy L, Shaw K, Smith A, Russell E, Van Uum S, Rieder M, Carleton B, Koren G.) Pediatr Res. 2015 Jul;78(1):44-7 PMID: 25790275 03/20/2015
Is it safe to use inhaled corticosteroids in pregnancy?

(Smy L, Chan AC, Bozzo P, Koren G.) Can Fam Physician. 2014 Sep;60(9):809-12, e433-5 PMID: 25217675 PMCID: PMC4162695 09/14/2014

Laura Smy, PhD

Assistant Professor

Locations

Specialties

Languages

Education

Clinical Expertise

Methodologies and Techniques

Leadership Positions

Publications